Man sieht genau Verlust Stevioside-Segment 2012 2.479.841 $ eindeutig wieder rückläufig im Vergleich zu FJ 2011 3.517.236 $ während die Med-Sparte trotz einer Million $ mehr Revenues als im Vorjahr immernoch 1.213.699 $ Verlust gemacht hat (Vorjahr 1.339.415 $ Verlust)
Corporate and Other expenses ordne ich mal pauschal 50:50 je 360.000 $ an Kosten 2012 zu.
von den 4.395.714 $ Gesamtverlust ordne ich also ca 1.600.000 $ der Med.-sparte zu.
Fazit für mich die chinesische Spedizinsparte kann ruhig weg und die Stevia-Sparte kann wie geplant die Produktion verdoppeln und somit auch den Umsatz.
For the Year Ended April 30, 2012 | ||||||||||||||||
Chinese Medicine | Stevioside | Corporate and Other | Consolidated | |||||||||||||
Revenues | $ | 3,102,167 | 9,830,011 | - | 12,932,178 | |||||||||||
Cost of goods sold | 2,823,069 | 8,194,121 | - | 11,017,190 | ||||||||||||
Gross profit | 279,098 | 1,635,890 | - | 1,914,988 | ||||||||||||
Loss on disposal of property and equipment | - | (673,931 | ) | - | (673,931 | ) | ||||||||||
Other operating expenses | 1,444,197 | 2,898,823 | 719,664 | 5,062,684 | ||||||||||||
Interest income | 13,930 | 59,224 | 12,287 | 85,441 | ||||||||||||
Other income (expense) | (62,530 | ) | (602,201 | ) | 5,203 | (659,528 | ) | |||||||||
Loss from continuing operations before income taxes and noncontrolling interest | $ | (1,213,699 | ) | (2,479,841 | ) | (702,174 | ) | (4,395,714 | ) |
F - 18
SUNWIN STEVIA INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
YEARS ENDED APRIL 30, 2012 AND 2011
For the Year Ended April 30, 2011 | ||||||||||||||||
Chinese Medicine | Stevioside | Corporate and Other | Consolidated | |||||||||||||
Revenues | $ | 2,274,651 | $ | 7,307,980 | $ | - | $ | 9,582,631 | ||||||||
Cost of goods sold | 2,088,098 | 6,042,753 | 8,130,851 | |||||||||||||
Gross profit | 186,553 | 1,265,227 | - | 1,451,780 | ||||||||||||
(Gain) loss on disposal of property and equipment | 1,024 | (1,181,325 | ) | - | (1,180,301 | ) | ||||||||||
Other operating expenses | 1,535,652 | 3,635,718 | 280,563 | 5,451,933 | ||||||||||||
Interest income | 8,486 | 34,365 | 5,260 | 48,111 | ||||||||||||
Other income | 174 | 215 | 6,165 | 6,554 | ||||||||||||
Loss from continuing operations before income taxes and noncontrolling interest | $ | (1,339,415 | ) | $ | (3,517,236 | ) | $ | (269,138 | ) | $ | (5,125,788 | ) |
NOTE 14 – CONCENTRATIONS AND CREDIT RISK
Werbung